[1] |
Kahal H, Aburima A, Ungvari T, et al.The effects of treatment with liraglutide on atherothrombotic risk in obese young women with polycystic ovary syndrome and controls[J]. BMC Endocr Disord,2015,15(1):45-47.
|
[2] |
Baldani D P, Skrgatic L, Ougouag R.Polycystic ovary syndrome: important underrecognised cardiometabolic risk factor in reproductive-age women[J]. Int J Endocrinol,2015,25(6):1-17.
|
[3] |
吴锐,丁瑶,周晴,等. 多囊卵巢综合征患者血浆半乳糖凝集素-3与慢性炎症和胰岛素抵抗的相关性研究[J]. 中华内分泌代谢杂志,2018,34(7):578-582.
|
[4] |
陈丽华,王秀丽,陈静,等. 血管紧张素Ⅱ和血管紧张素1-7及其受体在多囊卵巢综合征患者中的表达研究[J]. 中国全科医学,2017,20(24):2978-2983.
|
[5] |
宋颖,李蓉. 多囊卵巢综合征中国诊疗指南解读[J]. 实用妇产科杂志,2018,34(10):737-741.
|
[6] |
Ramezani Tehrani F, Montazeri SA, Hosseinpanah F, et al.Trend of cardio-metabolic risk factors in polycystic ovary syndrome: A population-based prospective cohort Study[J]. PLoS One,2015,10(9):609-611.
|
[7] |
Kosidou K, Dalman C, Widman L, et al.Maternal polycystic ovary syndrome and the risk of autism spectrum disorders in the offspring: A population-based nationwide study in Sweden[J]. Mol. Psychiatry,2016,21(10):1441-1448.
|
[8] |
Bagir GS, Bakiner OS, Bozkirli E, et al.Body mass index below obesity threshold implies similar cardiovascular risk among various polycystic ovary syndrome phenotypes[J]. Med Princ Pract,2015,25(1):61-66.
|
[9] |
李晓红,闫宏,温泰芳. 多囊卵巢综合征大鼠AMH表达与胰岛素抵抗的相关性研究[J]. 中国免疫学杂志,2015,31(6):835-837.
|
[10] |
甄鑫,颜桂军,孙海翔,等. 血管紧张素转换酶基因I/D多态性与多囊卵巢综合征的关系[J]. 中华妇幼临床医学杂志(电子版),2017,13(6):652-657.
|
[11] |
左宏玲,李晓冬,杜彦芳,等. 多囊卵巢综合征患者外周血Ang-(1-7)、Ang Ⅱ/Ang-(1-7)比值与胰岛素抵抗及脂代谢的相关性研究[J]. 中华生殖与避孕杂志,2017,37(5):366-370.
|
[12] |
张汝坚,付霞霏,潘淑芬,等. 多囊卵巢综合征患者血清半乳糖凝集素-3水平的变化及意义[J]. 中国妇幼保健,2018,33(3):504-508.
|
[13] |
李修阳,张宁,任健,等. 多囊卵巢综合征痰湿证患者血清代谢组学分析及其生物标志物筛选[J]. 山东医药,2015,55(37):15-18.
|
[14] |
易盛碧,史传,魏光绪,等. 血清炎性标志物与多囊卵巢综合征及其伴发胰岛素抵抗的关系[J]. 中国临床研究,2015,28(10):1294-1297.
|
[15] |
陈婷婷,傅萍,邢佳,等. 多囊卵巢综合征发病机制的影响因子研究[J]. 中国优生与遗传杂志,2016,24(11):122-125.
|